Nathalie Delesque-Touchard

Author

Sanofi (France)

Also Known As

N. Delesque-Touchard, N. Delesque‐Touchard, Nathalie Delesque-Touchard

Publications

856

Citations

H-Index

Concepts

All Affiliations

Sanofi (France)Vlaams Instituut voor Biotechnologie KU Leuven

About

Nathalie Delesque-Touchard is an author at Sanofi (France) specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	612
2	Health Sciences	1	1	122
3	Natural Sciences	1	1	311
4	Social Sciences	1	1	51
5	Biochemistry	1	1	311

Nathalie Delesque-Touchard

Publications

856

Citations

H-Index

Page 1

	Year	Citations
The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts Pierre Savi, Jean‐Luc Zachayus, Nathalie Delesque-Touchard, Proceedings of the National Academy of Sciences Active MetabolitePlatelet AntagonistCell SignalingBiochemistryLipid Rafts	2006	311
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes Marc Tjwa, Lola Bellido‐Martín, Yuan Lin, Blood	2007	158
Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes Oksana Kunduzova, Nathalie Alet, Nathalie Delesque-Touchard, The FASEB Journal Cellular PhysiologyInflammationMetabolic SyndromeAngiogenesisSignaling Pathway	2008	122
Synergistic Action of Hepatocyte Nuclear Factors 3 and 6 onCYP2C12 Gene Expression and Suppression by Growth Hormone-activated STAT5b Nathalie Delesque-Touchard, Soo-Hee Park, David J. Waxman Journal of Biological Chemistry	2000	75
Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity Antoine Alam, Jean-Pascal Hérault, Pauline Barron, Biochemical and Biophysical Research Communications AngiogenesisDevelopmental BiologyMedicineVascular BiologyNeovascularization	2004	64
A novel inhibitor of p75-neurotrophin receptor improves functional outcomes in two models of traumatic brain injury Sandrine Delbary-Gossart, Sangmi Lee, Marco Giorgio Baroni, Brain Traumatic Brain InjuryNovel InhibitorPro-nerve Growth FactorNeurochemical BiomarkersSynaptic Signaling	2016	51
Regulator of G-Protein Signaling 18 Controls Both Platelet Generation and Function Nathalie Delesque-Touchard, Caroline Pendaries, Cécile Volle‐Challier, PLoS ONE Platelet GenerationImmunologyBlood CellThrombosisBone Marrow Failure	2014	41
SAR216471, an alternative to the use of currently available P2Y12 receptor inhibitors? Nathalie Delesque-Touchard, A. M. Pflieger, Sandrine Bonnet-Lignon, Thrombosis Research Drug TargetMedicineDrug DiscoveryRational Drug DesignPharmacological Agent	2014	23
A New Synthetic FGF Receptor Antagonist Inhibits Arteriosclerosis in a Mouse Vein Graft Model and Atherosclerosis in Apolipoprotein E-Deficient Mice Frédérique Dol-Gleizes, Nathalie Delesque-Touchard, Anne-Marie Marés, PLoS ONE	2013	11

Page 1